Shanti G Duvur

Title: Shanti G Duvur: Innovator in Pharmaceutical Formulations

Introduction

Shanti G Duvur is a notable inventor based in Fremont, CA, recognized for his contributions to the field of pharmaceutical formulations. His innovative work focuses on creating stable liquid formulations that enhance the efficacy and stability of therapeutic antibodies.

Latest Patents

Duvur holds a patent for "Stable aqueous pharmaceutical formulations of daclizumab antibodies." This invention is directed to a stable liquid pharmaceutical formulation comprising a high concentration, e.g., 50 mg/ml or more, of antibody in about 20-60 mM succinate buffer or 30-70 mM histidine buffer, having a pH from about 5.5 to about 6.5, about 0.01-0.1% polysorbate, and a tonicity modifier that contributes to the isotonicity of the formulation. This liquid formulation is stable at refrigerated temperatures (2-8°C) for at least one year, and preferably two years. It is suitable for subcutaneous injection and includes preferred antibodies such as Daclizumab, a humanized anti-IL-2 receptor monoclonal antibody, among others.

Career Highlights

Throughout his career, Duvur has worked with prominent companies in the biotherapeutics sector, including AbbVie Biotherapeutics Inc. and Abbott Biotherapeutics Corporation. His experience in these organizations has contributed significantly to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Duvur has collaborated with talented professionals in the field, including Supriya Gupta and Elizabet Kaisheva, who have contributed to his research and development efforts.

Conclusion

Shanti G Duvur's work in pharmaceutical formulations exemplifies innovation in the healthcare industry. His patent for stable aqueous formulations demonstrates his commitment to improving therapeutic options for patients.